Literature DB >> 10952691

Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vessels.

H Dong1, Y Jiang, W C Cole, C R Triggle.   

Abstract

In the presence of L-NNA (100 microM), indomethacin (10 microM) and ODQ (10 microM), acetylcholine induced a concentration-dependent vasorelaxation of guinea-pig mesenteric and middle cerebral arteries precontracted with cirazoline or histamine, but not with high K(+), indicating the contribution of an endothelium-derived hyperpolarizing factor (EDHF). In cerebral arteries, charybdotoxin (ChTX; 0.1 microM) completely inhibited the indomethacin, L-NNA and ODQ-insensitive relaxation; iberiotoxin (IbTX, 0.1 microM), 4-aminopyridine (4-AP, 1 mM), or barium (30 microM) significantly reduced the response; in the mesenteric artery, ChTX and IbTX also reduced this relaxation. Glibenclamide (10 microM) had no affect in either the mesenteric or cerebral artery. Neither clotrimazole (1 microM) nor 7-ethoxyresorufin (3 microM) affected EDHF-mediated relaxation in the mesenteric artery, but abolished or attenuated EDHF-mediated relaxations in the cerebral artery. AM404 (30 microM), a selective anandamide transport inhibitor, did not affect the vasorelaxation response to acetylcholine in the cerebral artery, but in the mesenteric artery potentiated the vasorelaxation response to acetylcholine in an IbTX, and apamin-sensitive, but SR 141816A-insensitive manner. Ouabain (100 microM) almost abolished EDHF-mediated relaxation in the mesenteric artery, but enhanced the relaxation in the cerebral artery whereas the addition of K(+) (5 - 20 mM) to precontracted guinea-pig cerebral or mesenteric artery induced further vasoconstriction. These data suggest that in the guinea-pig mesenteric and cerebral arteries different EDHFs mediate acetylcholine-induced relaxation, however, EDHF is unlikely to be mediated by K(+).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952691      PMCID: PMC1572250          DOI: 10.1038/sj.bjp.0703474

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Advances in vascular neuroeffector mechanisms.

Authors:  S Guimarães; D Moura
Journal:  Trends Pharmacol Sci       Date:  1999-03       Impact factor: 14.819

2.  Structure-activity relationships in the induction of hepatic microsomal cytochrome P450 by clotrimazole and its structurally related compounds in rats.

Authors:  Y Matsuura; E Kotani; T Iio; T Fukuda; S Tobinaga; T Yoshida; Y Kuroiwa
Journal:  Biochem Pharmacol       Date:  1991-06-15       Impact factor: 5.858

Review 3.  Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium.

Authors:  S G Taylor; A H Weston
Journal:  Trends Pharmacol Sci       Date:  1988-08       Impact factor: 14.819

4.  Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.

Authors:  R J Gryglewski; S Moncada; R M Palmer
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

5.  Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus.

Authors:  A Galvez; G Gimenez-Gallego; J P Reuben; L Roy-Contancin; P Feigenbaum; G J Kaczorowski; M L Garcia
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

6.  Potassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase.

Authors:  H Ding; P Kubes; C Triggle
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

7.  Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583.

Authors:  H A Kontos; E P Wei
Journal:  Stroke       Date:  1993-03       Impact factor: 7.914

Review 8.  Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations.

Authors:  T Nagao; P M Vanhoutte
Journal:  Am J Respir Cell Mol Biol       Date:  1993-01       Impact factor: 6.914

9.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

10.  Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels.

Authors:  G Chen; H Suzuki; A H Weston
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

View more
  10 in total

Review 1.  Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses.

Authors:  Cor de Wit; Tudor M Griffith
Journal:  Pflugers Arch       Date:  2010-04-09       Impact factor: 3.657

2.  An investigation of the mechanisms of hydrogen sulfide-induced vasorelaxation in rat middle cerebral arteries.

Authors:  E Streeter; J Hart; E Badoer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-07-17       Impact factor: 3.000

3.  Endothelium-derived hyperpolarizing factor in the brain: influence of sex, vessel size and disease state.

Authors:  Catherine M Davis; Dominic A Siler; Nabil J Alkayed
Journal:  Womens Health (Lond)       Date:  2011-05

Review 4.  Microvascular responsiveness in obesity: implications for therapeutic intervention.

Authors:  Zsolt Bagi; Attila Feher; James Cassuto
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Selective blockade of endothelial Ca2+-activated small- and intermediate-conductance K+-channels suppresses EDHF-mediated vasodilation.

Authors:  Ines Eichler; Judith Wibawa; Ivica Grgic; Andrea Knorr; Susanne Brakemeier; Axel R Pries; Joachim Hoyer; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

6.  Evaluation of potassium ion as the endothelium-derived hyperpolarizing factor (EDHF) in the bovine coronary artery.

Authors:  Silvia Nelli; William S Wilson; Hilary Laidlaw; Andrea Llano; Susan Middleton; Andrew G Price; William Martin
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

7.  Myoendothelial gap junction frequency does not account for sex differences in EDHF responses in rat MCA.

Authors:  Elke M Sokoya; Alan R Burns; Sean P Marrelli; Jie Chen
Journal:  Microvasc Res       Date:  2007-04-06       Impact factor: 3.514

8.  Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor.

Authors:  Inmaculada C Villar; Catherine M Panayiotou; Adil Sheraz; Melanie Madhani; Ramona S Scotland; Muriel Nobles; Barbara Kemp-Harper; Amrita Ahluwalia; Adrian J Hobbs
Journal:  Cardiovasc Res       Date:  2007-03-03       Impact factor: 10.787

9.  Modulation of vasodilator response via the nitric oxide pathway after acute methyl mercury chloride exposure in rats.

Authors:  S Omanwar; B Saidullah; K Ravi; M Fahim
Journal:  Biomed Res Int       Date:  2013-08-19       Impact factor: 3.411

10.  Activation of endothelial transient receptor potential C3 channel is required for small conductance calcium-activated potassium channel activation and sustained endothelial hyperpolarization and vasodilation of cerebral artery.

Authors:  Mikhail Y Kochukov; Adithya Balasubramanian; Joel Abramowitz; Lutz Birnbaumer; Sean P Marrelli
Journal:  J Am Heart Assoc       Date:  2014-08-20       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.